Our Mission

To empower cancer patients with:

  • Ownership and control of their fundamental genomic and health data
  • Tools to analyze that data efficiently and make it readily available to their advisor
  • Information and expertise that allow them to discover, explore and access a variety of the most current personalized therapeutic options for their own care

Our Mission

To empower cancer patients with:
  • Ownership and control of their fundamental genomic and health data
  • Tools to analyze that data efficiently and make it readily available to their advisors
  • Information and expertise that allow them to discover, explore and access a variety of the most current personalized therapeutic options for their own care

Our Story

Diagnosed with Stage IV esophageal cancer, Stephen was given just four months to live. In search of treatment options, he sequenced his whole exome genome and used the data to identify and obtain access to novel immunotherapies including a personalized neoantigen vaccine.

He survived and thrived for three full years beyond expectations, and it became his mission to bring his approach to the masses.

Stephen passed away in July, 2020, due to complications from radiation treatments, not from the cancer itself. His loss only strengthens our resolve to make safer options faster and more accessible.

Learn More About Stephen’s Legacy

We are committed to

Guiding you to the genomic data you need to gather and store                                                                                                                                                         

Connecting you with expert providers to identify the best available and personalized treatment options for your genetically unique cancer

Providing guidance on gathering, storing, and interpreting data, and monitoring the status of your disease                                                        

Accelerating the adoption of the most advanced and sophisticated cancer treatments                                                                                                          

We are committed to

Guiding you to the genomic data you need to gather and store                                                                                                                                                         

Connecting you with expert providers to identify the best available and personalized treatment options for your genetically unique cancer

Providing guidance on gathering, storing, and interpreting data, and monitoring the status of your disease                                                        

Accelerating the adoption of the most advanced and sophisticated cancer treatments                                                                                                          

Our Vision

We envision a world in which all people with life-threatening diseases can use their genomic and health data as the catalyst toward optimal health and wellness.

Our Team

The Late Stephen Aldrich
The Late Stephen AldrichCo Founder
Michael Gallay
Michael GallaySenior Product Manager
James Inglis-Jones
James Inglis-JonesFounding Member
 Ignat Leshchiner
Ignat LeshchinerScientific Advisor
Joerg Matthiessen
Joerg MatthiessenFounding Member
Loraine McLellan
Loraine McLellanFounding Member
Andrew Popp
Andrew PoppTechnical Founder & Advisor
Brad Power
Brad PowerFounding Member